DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$78.55
-0.77 (-0.97%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-50.6% upside
Low Target
$27.89
Average Target
$38.82
High Target
$53.79
Current Price
$78.55
Current
$78.55
$78.55
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Scenario Analysis
Bear Case
$27.89
-64.5%
Low target
Base Case
$38.82
-50.6%
Avg target
Bull Case
$53.79
+-31.5%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$88.02
-10.8% from high
52-Week Low
$13.37
+487.7% from low
50-Day SMA
$45.37
+73.1% vs SMA
200-Day SMA
$31.95
+145.9% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$38.82
-55.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |